AU2001248760A1 - Preventives/remedies for alzheimer's disease - Google Patents

Preventives/remedies for alzheimer's disease

Info

Publication number
AU2001248760A1
AU2001248760A1 AU2001248760A AU4876001A AU2001248760A1 AU 2001248760 A1 AU2001248760 A1 AU 2001248760A1 AU 2001248760 A AU2001248760 A AU 2001248760A AU 4876001 A AU4876001 A AU 4876001A AU 2001248760 A1 AU2001248760 A1 AU 2001248760A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
alzheimer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248760A
Inventor
Shuichi Furuya
Nobuhiro Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001248760A1 publication Critical patent/AU2001248760A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001248760A 2000-04-13 2001-04-13 Preventives/remedies for alzheimer's disease Abandoned AU2001248760A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000112046 2000-04-13
JP2000-112046 2000-04-13
PCT/JP2001/003189 WO2001078780A1 (en) 2000-04-13 2001-04-13 Preventives/remedies for alzheimer's disease

Publications (1)

Publication Number Publication Date
AU2001248760A1 true AU2001248760A1 (en) 2001-10-30

Family

ID=18624280

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248760A Abandoned AU2001248760A1 (en) 2000-04-13 2001-04-13 Preventives/remedies for alzheimer's disease

Country Status (5)

Country Link
US (1) US20030134863A1 (en)
EP (1) EP1393747A4 (en)
AU (1) AU2001248760A1 (en)
CA (1) CA2406832A1 (en)
WO (1) WO2001078780A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288102A1 (en) * 2000-09-22 2002-04-02 Takeda Chemical Industries Ltd. Solid preparations
IL156777A0 (en) 2001-04-30 2004-02-08 Zentaris Gmbh Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
DE10137174A1 (en) * 2001-07-31 2003-02-13 Zentaris Ag Method of modifying T-cell populations, e.g. for treatment of HIV infection or cancer, comprises administrating luteinizing hormone releasing hormone antagonist at controlled dose insufficient to cause chemical castration
WO2003064429A1 (en) * 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, process for preparing the same and use thereof
BRPI0407082C1 (en) 2003-01-29 2021-05-25 Takeda Pharmaceuticals Co n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3 compound, 4-Tetrahydrothieno[2,3-d]pyrimidine-6-yl)phenyl)-n'-methoxyurea, or a salt thereof, pharmaceutical, and, use of the compound
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
US9283211B1 (en) 2009-11-11 2016-03-15 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
TW201130854A (en) * 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
US9700544B2 (en) 2013-12-31 2017-07-11 Neal K Vail Oral rapamycin nanoparticle preparations
CN111574534B (en) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 Phenyl-substituted thieno [2,3-d ] pyrimidine-2, 4(1H,3H) -diones and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048863A (en) * 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
UY23948A1 (en) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd DERIVATIVES FROM THYPHENE CONDENSED RINGS, THEIR PRODUCTION AND USE.
CA2250908C (en) * 1996-04-30 2012-03-13 Takeda Chemical Industries, Ltd. Combined use of gnrh agonist and antagonist
RU2233284C2 (en) * 1999-03-24 2004-07-27 Такеда Кемикал Индастриз, Лтд. Thienopyrimidine derivatives, method for their preparing, pharmaceutical composition and method for antagonization of gonadotropin-releasing hormone
TWI225863B (en) * 1999-03-24 2005-01-01 Takeda Chemical Industries Ltd Thienopyrimidine compounds, their production and use

Also Published As

Publication number Publication date
CA2406832A1 (en) 2002-10-10
EP1393747A1 (en) 2004-03-03
US20030134863A1 (en) 2003-07-17
EP1393747A4 (en) 2004-03-03
WO2001078780A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001273132A1 (en) Compounds to treat alzheimer's disease
AU2002219824A1 (en) Compositions and methods for diagnosing alzheimer's disease
AU2001278084A1 (en) Model for alzheimer's disease and other neurodegenerative diseases
AU1407399A (en) Treatment for alzheimer's disease
AU2610901A (en) Predictive diagnostic for alzheimer's disease
AU2001286221A1 (en) Remedies for ischemic diseases
AU2639299A (en) Remedies/preventives for parkinson's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2001281034A1 (en) Alzheimer's tester
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2001248760A1 (en) Preventives/remedies for alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
AU2002224022A1 (en) Preventives or remedies for endoplasmic reticulum stress-associated diseases
AU2002232419A1 (en) Clinician's assistant system
AU2001241162A1 (en) Remedies for allergic diseases
AU2001236006A1 (en) Preventives/remedies for kidney diseases
AU2001267826A1 (en) Remedies for alzheimer's disease
AU2002242348A1 (en) Process for obtaining 3'-epilutein
AU2001271026A1 (en) Remedies for bone diseases
AU2002232401A1 (en) Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease
AU2001228863A1 (en) Remedies for ophthalmic diseases